Search
Now showing items 1-10 of 11
Lifestyle behaviours and health measures of women at increased risk of breast cancer taking chemoprevention.
(Lippincott, Williams & Wilkins, 2018-11-15)
Women at increased breast cancer (BC) risk are eligible for chemoprevention. Healthy lifestyles are potentially important for these women to improve efficacy and minimise side effects of chemoprevention and reduce the risk ...
Breast cancer risk in a screening cohort of Asian and white British/Irish women from Manchester UK.
(2018-01-25)
BACKGROUND: The differences between breast cancer risk factors in white British/Irish and Asian women attending screening in the UK are not well documented. METHODS: Between 2009-15 ethnicity and traditional breast cancer ...
Overweight and breast cancer risk in the International Breast Cancer Intervention studies I and II
(American Society of Clinical Oncology, 2018-05-20)
Background: Overweight increases breast cancer risk in population risk postmenopausal women. Data from the National Surgical Adjuvant Breast and Bowel Project (NSABP) P1 and P2 chemoprevention trials indicate premenopausal ...
The impact of body mass index on breast cancer incidence among women at increased risk: an observational study from the International Breast Intervention Studies
(Springer Nature, 2021-03-03)
Background We investigated the association between body mass index (BMI) and breast cancer risk in women at increased
risk of breast cancer receiving tamoxifen or anastrozole compared with placebo using data from the ...
Tamoxifen related side effects and their impact on breast cancer incidence: A retrospective analysis of the randomised IBIS-I trial.
(Elsevier, 2020-10-31)
BACKGROUND: Studies in the adjuvant setting have shown that endocrine therapy related side effects predict breast cancer recurrence risk. Here, we assess the relationship between early reported side effects and incidence ...
Final Results of the Prospective FH02 Mammographic Surveillance Study of Women Aged 35-39 at Increased Familial Risk of Breast Cancer.
(2019-01)
Background: Many women who are at increased risk of breast cancer due to a mother or sister diagnosed with breast cancer aged under 40 do not currently qualify for surveillance before 40 years of age. There are almost no ...
Participant-reported symptoms as predictors of long-term adherence of endocrine therapy in the International breast cancer intervention studies 2 (IBIS-2)
(American Association for Cancer Research, 2018-02)
Background: Aromatase inhibitors (AIs) reduce the risk of breast cancer in women at increased risk and reduce recurrence in those with ductal carcinoma in situ (DCIS) (IBIS-2, MAP.3, NSABP B-33). The effectiveness of AIs ...